Postoperative radiotherapy (PORT) for early oral cavity cancer (pT1-2,N0-1): A review

2019 ◽  
Vol 143 ◽  
pp. 67-75 ◽  
Author(s):  
Eliana Ivaldi ◽  
Dalila Di Mario ◽  
Alberto Paderno ◽  
Cesare Piazza ◽  
Paolo Bossi ◽  
...  
2003 ◽  
Vol 21 (2) ◽  
pp. 327-333 ◽  
Author(s):  
Lisa Licitra ◽  
Cesare Grandi ◽  
Marco Guzzo ◽  
Luigi Mariani ◽  
Salvatore Lo Vullo ◽  
...  

Purpose: Prognosis of patients with advanced oral cavity cancer is worth improving. Chemotherapy has been reported to be especially active in oral cavity tumors. Here we repeat the results of a randomized, multicenter trial enrolling patients with a resectable, stage T2–T4 (> 3 cm), N0–N2, M0 untreated, squamous cell carcinoma of the oral cavity. Patients and Methods: Patients were randomly assigned to three cycles of cisplatin and fluorouracil followed by surgery (chemotherapy arm) or surgery alone (control arm). In both arms, postoperative radiotherapy was reserved to high-risk patients, and surgery was modulated depending on the tumor’s closeness to the mandible. Patients’ accrual was opened in 1989 and closed in 1999. It included 195 patients. Results: In the chemotherapy arm, three toxic deaths were recorded. No significant difference in overall survival was found. Five-year overall survival was, for both arms, 55%. Postoperative radiotherapy was administered in 33% of patients in the chemotherapy arm, versus 46% in the control arm. A mandible resection was performed in 52% of patients in the control arm, versus 31% in the chemotherapy arm. Conclusion: The addition of primary chemotherapy to standard surgery was unable to improve survival. However, in this study, primary chemotherapy seemed to play a role in reducing the number of patients who needed to undergo mandibulectomy and/or radiation therapy. Variations in the criteria used to select patients for these treatment options may make it difficult to generalize these results, but there appears to be room for using preoperative chemotherapy to spare demolitive surgery and/or radiation therapy in patients with advanced, resectable oral cavity cancer.


Head & Neck ◽  
2014 ◽  
Vol 37 (7) ◽  
pp. 933-939 ◽  
Author(s):  
Shih-Hua Liu ◽  
K.S. Clifford Chao ◽  
Yi-Shing Leu ◽  
Jehn-Chuan Lee ◽  
Chung-Ji Liu ◽  
...  

2021 ◽  
Vol 19 (1) ◽  
Author(s):  
Tsung-You Tsai ◽  
Yenlin Huang ◽  
Andrea Iandelli ◽  
Shiao-Fwu Tai ◽  
Shao-Yu Hung ◽  
...  

Abstract Background The administration of postoperative radiotherapy remains controversial in pN1 oral cavity cancer patients without extranodal extension. The aim is to determine whether postoperative radiotherapy reduces the neck recurrence rate and improves the survival outcomes of pN1 patients. Methods This study consecutively enrolled 1056 patients with newly diagnosed oral squamous cell carcinoma who underwent tumor wide excision and neck dissection from September 2002 to November 2019. One hundred two pN1 patients without extranodal extension were eligible for analysis. Then, a subgroup analysis of 40 patients was performed after patients with other adverse risk factors (positive margins, close margins, lymphovascular invasion, perineural invasion, tumor depth ≥ 10 mm, and poor histological differentiation) were excluded. Results Of the 102 eligible pN1 patients, 26 patients received surgery alone, and 76 received postoperative radiotherapy. No significant differences were observed in the neck recurrence rate (7.7% vs. 15.8%, p = 0.30). Similarly, in patients without other adverse risk factors, no significant differences were observed in the neck recurrence rate (5% vs. 20%, p = 0.15) between surgery alone group and postoperative radiotherapy group. Moreover, no significant difference was found in the neck recurrence-free survival rate, overall survival, and disease-specific survival (77.1% vs. 52.5%, p = 0.42, 83.5% vs. 64.5%, p = 0.81, and 88.2% vs. 67.9%, p = 0.34, respectively). Conclusion Postoperative radiotherapy did not significantly decrease the probability of neck recurrence and survival outcomes in pN1 patients without extranodal extension. Radical surgery alone may be considered sufficient treatment for pN1 patients without other adverse risk factors.


2019 ◽  
Vol 132 ◽  
pp. 6
Author(s):  
K. Carlwig ◽  
B. Zackrisson ◽  
P. Nilsson ◽  
E. Kjellén ◽  
E. Brun ◽  
...  

2017 ◽  
Vol 143 (7) ◽  
pp. 691 ◽  
Author(s):  
Michael T. Spiotto ◽  
Gina Jefferson ◽  
Barry Wenig ◽  
Michael Markiewicz ◽  
Ralph R. Weichselbaum ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document